DJIA 18,214.42 0.00 0.00%
NASDAQ 4,987.89 0.00 0.00%
S&P 500 2,110.74 0.00 0.00%
market minute promo

Exelixis (NASDAQ: EXEL)

2.93 0.00 (0.00%)

REAL-TIME: Last trade at

Extended Hours: $2.87 -$0.06 (-2.05%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

EXEL $2.93 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $2.70
Previous Close $2.93
Daily Range $2.63 - $2.94
52-Week Range $1.26 - $7.58
Market Cap $572.0M
P/E Ratio -1.95
Dividend (Yield) $0.00 (0.0%)
Volume 6,088,120
Average Daily Volume 4,331,382
Current FY EPS -$1.03




Drug Makers

Exelixis (EXEL) Description

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases. Website:

News & Commentary

Looking Ahead at Exelixis, Inc.

The biotech faces two major value-creating events in 2015.

Exelixis' (EXEL) CEO Mike Morrissey on Q4 2014 Results - Earnings Call Transcript

Exelixis (EXEL) Q4 2014 Results - Earnings Call Webcast

Will Exelixis (EXEL) Miss Estimates this Earnings Season? - Analyst Blog

Why Shares of Exelixis, Inc. Briefly Spiked Higher

Exelixis shares popped briefly Thursday. Here's why.

Morning Market Gainers

Benzinga's Top #PreMarket Gainers

Even With Recent Exelixis Price Action, Outlook Remains Unchanged

Exelixis: Expected METEOR Trial Success Changes Everything

Wednesday's ETF Movers: XBI, ILF

See More EXEL News...

EXEL's Top Competitors

EXEL $2.93 (0.00%)
Current stock: EXEL
TMO $130.14 (0.00%)
Current stock: TMO
ILMN $198.46 (0.00%)
Current stock: ILMN
WAT $120.93 (0.00%)
Current stock: WAT